These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38646561)

  • 1. Risk factors for anxiety and its impacts on acute exacerbation in older patients with chronic obstructive pulmonary disease.
    Mou Y; Shan L; Liu Y; Wang Y; He Z; Li X; Zhu H; Ge H
    Front Med (Lausanne); 2024; 11():1340182. PubMed ID: 38646561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members.
    Pasquale MK; Xu Y; Baker CL; Zou KH; Teeter JG; Renda AM; Davis CC; Lee TC; Bobula J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():111-21. PubMed ID: 26834468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
    Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic obstructive pulmonary disease assessment test: usefulness for monitoring recovery and predicting poor course of disease after exacerbations.
    Pulido Herrero E; García Gutiérrez S; Antón Ladislao A; Piñera Salmerón P; Martín Corral MJ; Gorordo Unzueta MI; Lopetegui Eraso P; García Lamberechts EJ; Quintana López JM
    Emergencias; 2019 Feb; 31(1):21-26. PubMed ID: 30656869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of the distance-saturation product and low-attenuation area percentage in pulmonary computed tomography with acute exacerbation in patients with chronic obstructive pulmonary disease.
    Chen KY; Kuo HY; Lee KY; Feng PH; Wu SM; Chuang HC; Chen TT; Sun WL; Tseng CH; Liu WT; Cheng WH; Majumdar A; Stettler M; Tsai CY; Ho SC
    Front Med (Lausanne); 2022; 9():1047420. PubMed ID: 36687440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
    Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
    Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of the Cumulative Illness Rating Scale (CIRS) in Estimating the Impact of Comorbidities on Chronic Obstructive Pulmonary Disease (COPD) Outcomes: A Pilot Study of the MACH (Multidimensional Approach for COPD and High Complexity) Study.
    Di Raimondo D; Pirera E; Pintus C; De Rosa R; Profita M; Musiari G; Siscaro G; Tuttolomondo A
    J Pers Med; 2023 Nov; 13(12):. PubMed ID: 38138901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD.
    Sun T; Li X; Cheng W; Peng Y; Zhao Y; Liu C; Zeng Y; Chen Y; Cai S; Chen P
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1899-1907. PubMed ID: 32848378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different Clusters in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Two-Center Study in Brazil.
    Zucchi JW; Franco EAT; Schreck T; Castro E Silva MH; Migliorini SRDS; Garcia T; Mota GAF; de Morais BEB; Machado LHS; Batista ANR; de Paiva SAR; de Godoy I; Tanni SE
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2847-2856. PubMed ID: 33192058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical Characteristics and Outcomes in Non-Frequent Exacerbation Patients with Chronic Obstructive Pulmonary Disease in the Chinese Population.
    Liu D; Song Q; Zeng Y; Yi R; Liu Y; Li X; Chen Y; Cai S; Chen P
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1741-1751. PubMed ID: 37599897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease].
    Tan M; Jian W; Liang Q; Li S; Cui H
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1119-1124. PubMed ID: 34308866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of health status do not change over three-year periods and exacerbation makes difference in chronic obstructive pulmonary disease.
    Ferrari R; Tanni SE; Caram LM; Naves CR; Godoy I
    Health Qual Life Outcomes; 2011 Dec; 9():112. PubMed ID: 22152155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients.
    Bu XN; Yang T; Thompson MA; Hutchinson AF; Irving LB
    Singapore Med J; 2011 Dec; 52(12):894-900. PubMed ID: 22159933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between depression and anxiety index and frequency of acute exacerbation in chronic obstructive pulmonary disease.
    Hong YJ; Kim Y; Moon JY; Park S; Lee JK; Jung KS; Yoo KH; Kim YI; Choi JY
    Ther Adv Respir Dis; 2023; 17():17534666231216591. PubMed ID: 38108295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk factors for acute exacerbation of chronic obstructive pulmonary disease in patients who survived the Wenchuan earthquake].
    Ma CL; Xiao J; Wang K; Xu ZB; Chen B; Yin C; Feng YL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 43(4):566-72. PubMed ID: 22997898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
    Kawamatawong T; Onnipa J; Suwatanapongched T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.
    Mittal R; Chhabra SK
    COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL).
    Yang T; Cai B; Cao B; Kang J; Wen F; Chen Y; Jian W; Wang C
    Ther Adv Respir Dis; 2023; 17():17534666231167353. PubMed ID: 37073797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study.
    Zhou Z; Zhou A; Peng Y; Duan J; Zeng Y; Zhao Y; Cheng W; Chen P
    Respiration; 2020; 99(7):606-616. PubMed ID: 32659763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.